Suppr超能文献

用于治疗隐静脉搭桥移植血管病变的球囊血管成形术。

Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts.

作者信息

de Feyter P J, van Suylen R J, de Jaegere P P, Topol E J, Serruys P W

机构信息

Catheterization Laboratory, Thoraxcenter, University Hospital, Rotterdam-Dijkzigt, The Netherlands.

出版信息

J Am Coll Cardiol. 1993 Jun;21(7):1539-49. doi: 10.1016/0735-1097(93)90366-9.

Abstract

OBJECTIVES

The purpose of this review is to assess the value and limitations of balloon angioplasty for the treatment of saphenous vein bypass graft obstructions. The potential efficacy of new interventional techniques is discussed.

BACKGROUND

Treatment of ischemia due to saphenous vein bypass graft obstructions poses a difficult problem that will be encountered more often as the pool of surgically treated patients continues to accumulate. Reoperation is technically demanding and is associated with high mortality and morbidity rates. Balloon angioplasty may provide a suitable alternative.

METHODS

The review proposes a classification of patients with attempted saphenous vein graft angioplasty according to expected early and late outcome based on the data obtained from the relevant published data and personal experience.

RESULTS

Angioplasty of a nonocclusive obstruction in a saphenous vein bypass graft has an initial success rate of approximately 90% and is a safe procedure (procedural death rate < 1%, myocardial infarction rate < 4%). The overall average restenosis rate is 42%. Surgical standby is limited and technically difficult. Angioplasty of chronic total occlusions in old grafts is associated with poor initial and long-term results. The long-term clinical results are unfavorable because of the continuing progression of disease in nontreated vein graft segments and native coronary arteries, in addition to the high restenosis rate. New techniques, although promising, have shown neither better initial results nor reduction of restenosis. Stent placement may be useful in longer graft lesions containing friable material.

CONCLUSIONS

Patients may be classified into three groups according to expected early and late outcome on the basis of 1) unfavorable graft anatomy, 2) risk of cardiogenic shock in event of acute graft closure, and 3) age of grafts. The three groups are 1) those with an initial high success, low procedural risk and low restenosis rate; 2) those with an initial high success but high procedural risk and moderate to high restenosis rate; and 3) those with a low success, high risk and high restenosis rate. Balloon angioplasty to treat lesions in venous bypass grafts should be considered a palliative procedure, not a long-term solution, for ongoing progression of coronary artery and vein graft disease. The induced high restenosis rate remains a significant problem.

摘要

目的

本综述旨在评估球囊血管成形术治疗隐静脉搭桥移植血管阻塞的价值及局限性。并探讨新介入技术的潜在疗效。

背景

因隐静脉搭桥移植血管阻塞导致的缺血治疗是一个难题,随着接受手术治疗的患者数量不断增加,这一问题将更为常见。再次手术技术要求高,且死亡率和发病率也很高。球囊血管成形术可能是一种合适的替代方法。

方法

本综述根据从相关已发表数据和个人经验中获得的数据,按照预期的早期和晚期结果,对尝试进行隐静脉移植血管成形术的患者进行分类。

结果

隐静脉搭桥移植血管非闭塞性阻塞的血管成形术初始成功率约为90%,且是一种安全的手术(手术死亡率<1%,心肌梗死率<4%)。总体平均再狭窄率为42%。手术备用有限且技术难度大。旧移植血管慢性完全闭塞的血管成形术初始和长期结果均较差。由于未治疗的静脉移植血管段和自身冠状动脉疾病持续进展,再加上再狭窄率高,长期临床结果不佳。新技术虽然前景广阔,但初始结果并未更好,再狭窄率也未降低。支架置入术可能对含有易碎物质的较长移植血管病变有用。

结论

根据预期的早期和晚期结果,患者可分为三组,依据为:1)移植血管解剖结构不佳;2)急性移植血管闭塞时发生心源性休克的风险;3)移植血管的年限。这三组分别为:1)初始成功率高、手术风险低且再狭窄率低的患者;2)初始成功率高但手术风险高且再狭窄率为中度至高度的患者;3)成功率低、风险高且再狭窄率高的患者。对于冠状动脉和静脉移植血管疾病的持续进展,球囊血管成形术治疗静脉搭桥移植血管病变应被视为一种姑息性手术,而非长期解决方案。所导致的高再狭窄率仍然是一个重大问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验